Dermatol. praxi. 2009;3(4):184-187

Treatment of actinic keratoses

MUDr.Radek Litvik1,2, MUDr.Martin Paciorek2, MUDr.Yvetta Vantuchová, Ph.D.1
1 Kožní oddělení
2 Centrum plastické chirurgie a chirurgie ruky

Actinic keratoses are a sun induced cutaneous lesion, currently considered as a squamous cell carcinoma in situ that has the potencial to

progress to invasive SCC. To treat them, numerous, ablative and no ablative, therapeutic approaches exist. Among them, imiquimod,

a toll like receptor agonist, is effective and safe with an acceptable tolerability in the treatment of AK.

Keywords: actinic keratosis, imiquimod

Published: May 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Litvik R, Paciorek M, Vantuchová Y. Treatment of actinic keratoses. Dermatol. praxi. 2009;3(4):184-187.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Borecká D. Súčasné možnosti liečby aktinických keratóz. Derma 2008; 2: 32-33.
    2. Pizinger K. Kožní maligní epitelové nádory. Referátorový výběr z dermatovenerologie 2007; 1(speciál): 18-23.
    3. Roewert-Huber J, Stockfleth E, Kerl H. Pathology and pathobiology of actinic (solar) keratoris - an update. Br J Dermatol 2007; 157(Suppl 2): 18-20. Go to original source... Go to PubMed...
    4. Poláková K. Imiquimod verzus ostatné terapeutické modality v liečbe aktinických keratóz - výhoda liečby rakovinového poľa. Derma 2008; 3: 42-43.
    5. Urbanček S. Imiquimod rozšiřuje liečebné spektrum aktinických keratóz. Derma 2008; 4: 40-41.
    6. Hegyi J. Solárne keratózy. Referátorový výběr z dermatovenerologie 2007; 2: 28-32.
    7. Vatve M, Ortonne JP, Birch-Machin MA, Gupta G. Management of field change in actinic keratosis. Br J Dermatol 2007; 157(Suppl 2): 21-24. Go to original source... Go to PubMed...
    8. Schön MP, Schön M. Imiquimod: mode of action. Br J Dermatol 2007; 157(Suppl 2): 8-13. Go to original source... Go to PubMed...
    9. Stockfleth E, Sterry W, Carey-Yard m, Bichel J. Multicentre, open-label study using imiquimod 5% cream in one or two 4-week courses of treatment for multiple actinic keratoses on the head. Br J Dermatol 2007; 157(Suppl 2): 41-46. Go to original source... Go to PubMed...
    10. Krawtchenko N, Roewert-Huber J, Ulrich M, et al. A randomised study of topical 5% imiquimod cream vs. topical 5-fluorouracil vs. cryosurgery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1-year follow-up. Br J Dermatol 2007; 157(Suppl 2): 34-40. Go to original source... Go to PubMed...
    11. Ulrich C, Bichel J, Euvrard S, Guidi B, et al. Topical immunomodulation under systemic immunosuppression: results of a multicentre, randomized, placebo-controlled safety and efficacy study of imiquimod 5% cream for the treatment of actinic keratoses in kidney, heart, and liveer transplantant patients. Br J Dermatol 2007; 157(Suppl 2): 25-31. Go to original source... Go to PubMed...

    Return to the content


    Dermatology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.